37079222|t|Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
37079222|a|Alzheimer's disease (AD) is an age-related, multifactorial progressive neurodegenerative disorder manifested by cognitive impairment and neuronal death in the brain areas like hippocampus, yet the precise neuropathology of AD is still unclear. Continuous failure of various clinical trial studies demands the utmost need to explore more therapeutic targets against AD. Type 2 Diabetes Mellitus and neuronal insulin resistance due to serine phosphorylation of Insulin Receptor Substrate-1 at 307 exhibits correlation with AD. Dipeptidyl Peptidase-4 inhibitors (DPP-4i) have also indicated therapeutic effects in AD by increasing the level of Glucagon-like peptide-1 in the brain after crossing Blood Brain Barrier. The present study is hypothesized to examine Linagliptin, a DPP-4i in intracerebroventricular streptozotocin induced neurodegeneration, and neuroinflammation and hippocampal insulin resistance in rat model of AD. Following infusion on 1st and 3rd day, animals were treated orally with Linagliptin (0.513 mg/kg, 3 mg/kg, and 5 mg/kg) and donepezil (5 mg/kg) as a standard for 8 weeks. Neurobehavioral, biochemical and histopathological analysis was done at the end of treatment. Dose-dependently Linagliptin significantly reversed behavioral alterations done through locomotor activity (LA) and morris water maze (MWM) test. Moreover, Linagliptin augmented hippocampal GLP-1 and Akt-ser473 level and mitigated soluble Abeta (1-42), IRS-1 (s307), GSK-3beta, TNF-alpha, IL-1beta, IL-6, AchE and oxidative/nitrosative stress level. Histopathological analysis also exhibited neuroprotective and anti-amylodogenic effect in Hematoxylin and eosin and Congo red staining respectively. The findings of our study concludes remarkable dose-dependent therapeutic potential of Linagliptin against neuronal insulin resistance via IRS-1 and AD-related complication. Thus, demonstrates unique molecular mechanism that underlie AD.
37079222	24	29	DPP-4	Gene	25253
37079222	40	51	Linagliptin	Chemical	MESH:D000069476
37079222	60	77	Neurodegeneration	Disease	MESH:D019636
37079222	88	106	Insulin Resistance	Disease	MESH:D007333
37079222	111	128	Neuroinflammation	Disease	MESH:D000090862
37079222	164	178	Streptozotocin	Chemical	MESH:D013311
37079222	182	185	Rat	Species	10116
37079222	195	214	Alzheimer's Disease	Disease	MESH:D000544
37079222	216	235	Alzheimer's disease	Disease	MESH:D000544
37079222	237	239	AD	Disease	MESH:D000544
37079222	287	313	neurodegenerative disorder	Disease	MESH:D019636
37079222	328	348	cognitive impairment	Disease	MESH:D003072
37079222	353	367	neuronal death	Disease	MESH:D009410
37079222	439	441	AD	Disease	MESH:D000544
37079222	581	583	AD	Disease	MESH:D000544
37079222	585	609	Type 2 Diabetes Mellitus	Disease	MESH:D003924
37079222	623	641	insulin resistance	Disease	MESH:D007333
37079222	675	703	Insulin Receptor Substrate-1	Gene	25467
37079222	737	739	AD	Disease	MESH:D000544
37079222	827	829	AD	Disease	MESH:D000544
37079222	857	880	Glucagon-like peptide-1	Gene	24952
37079222	975	986	Linagliptin	Chemical	MESH:D000069476
37079222	1024	1038	streptozotocin	Chemical	MESH:D013311
37079222	1047	1064	neurodegeneration	Disease	MESH:D019636
37079222	1070	1087	neuroinflammation	Disease	MESH:D000090862
37079222	1104	1122	insulin resistance	Disease	MESH:D007333
37079222	1126	1129	rat	Species	10116
37079222	1139	1141	AD	Disease	MESH:D000544
37079222	1215	1226	Linagliptin	Chemical	MESH:D000069476
37079222	1267	1276	donepezil	Chemical	MESH:D000077265
37079222	1425	1436	Linagliptin	Chemical	MESH:D000069476
37079222	1564	1575	Linagliptin	Chemical	MESH:D000069476
37079222	1598	1603	GLP-1	Gene	24952
37079222	1608	1611	Akt	Gene	24185
37079222	1661	1666	IRS-1	Gene	25467
37079222	1675	1684	GSK-3beta	Gene	84027
37079222	1686	1695	TNF-alpha	Gene	24835
37079222	1697	1705	IL-1beta	Gene	24494
37079222	1707	1711	IL-6	Gene	24498
37079222	1713	1717	AchE	Gene	83817
37079222	1848	1869	Hematoxylin and eosin	Chemical	-
37079222	1874	1883	Congo red	Chemical	MESH:D003224
37079222	1994	2005	Linagliptin	Chemical	MESH:D000069476
37079222	2023	2041	insulin resistance	Disease	MESH:D007333
37079222	2046	2051	IRS-1	Gene	25467
37079222	2056	2058	AD	Disease	MESH:D000544
37079222	2141	2143	AD	Disease	MESH:D000544
37079222	Association	MESH:D000544	24952
37079222	Association	MESH:D013311	MESH:D000544
37079222	Negative_Correlation	MESH:D000069476	84027
37079222	Negative_Correlation	MESH:D000069476	24835
37079222	Negative_Correlation	MESH:D000069476	MESH:D013311
37079222	Positive_Correlation	MESH:D000069476	24952
37079222	Negative_Correlation	MESH:D000069476	MESH:D000090862
37079222	Negative_Correlation	MESH:D000069476	MESH:D000544
37079222	Negative_Correlation	MESH:D000069476	83817
37079222	Positive_Correlation	MESH:D013311	MESH:D007333
37079222	Negative_Correlation	MESH:D000069476	24498
37079222	Positive_Correlation	MESH:D013311	MESH:D019636
37079222	Negative_Correlation	MESH:D000069476	25467
37079222	Negative_Correlation	MESH:D000069476	MESH:D019636
37079222	Association	MESH:D000544	25467
37079222	Negative_Correlation	MESH:D000069476	24494
37079222	Negative_Correlation	MESH:D000069476	25253
37079222	Negative_Correlation	MESH:D000069476	MESH:D007333
37079222	Association	MESH:D007333	25467
37079222	Positive_Correlation	MESH:D013311	MESH:D000090862
37079222	Positive_Correlation	MESH:D000069476	24185

